N-(2-(6H-indolo[2,3-b]quinoxalin-6-yl)ethyl)-3-morpholinopropan-1-amine

ID: ALA4075250

Chembl Id: CHEMBL4075250

PubChem CID: 137651807

Max Phase: Preclinical

Molecular Formula: C23H27N5O

Molecular Weight: 389.50

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  c1ccc2nc3c(nc2c1)c1ccccc1n3CCNCCCN1CCOCC1

Standard InChI:  InChI=1S/C23H27N5O/c1-4-9-21-18(6-1)22-23(26-20-8-3-2-7-19(20)25-22)28(21)13-11-24-10-5-12-27-14-16-29-17-15-27/h1-4,6-9,24H,5,10-17H2

Standard InChI Key:  MWOIGQWTBZSCGB-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4075250

    ---

Associated Targets(non-human)

CV-1 (316 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vaccinia virus (4609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L929 (3802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Splenocyte (1641 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vesicular stomatitis virus (4460 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 389.50Molecular Weight (Monoisotopic): 389.2216AlogP: 3.05#Rotatable Bonds: 7
Polar Surface Area: 55.21Molecular Species: BASEHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.05CX LogP: 2.89CX LogD: 0.33
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.49Np Likeness Score: -1.33

References

1. Klimenko K, Lyakhov S, Shibinskaya M, Karpenko A, Marcou G, Horvath D, Zenkova M, Goncharova E, Amirkhanov R, Krysko A, Andronati S, Levandovskiy I, Polishchuk P, Kuz'min V, Varnek A..  (2017)  Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents.,  27  (16): [PMID:28666733] [10.1016/j.bmcl.2017.06.035]

Source